Arthrosi Therapeutics IPO

Arthrosi Therapeutics, founded in 2018, is a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. The company offers research and development services in the clinical stage, specifically targeted at treatments for gout and chronic kidney disease, with the goal of facilitating healthcare professionals in delivering effective uric acid reduction and the healing of joint damage brought on by tophi. Arthrosi Therapeutics is headquartered in San Diego, California.

Register for Details

For more details on financing and valuation for Arthrosi Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Arthrosi Therapeutics

Forge green plus iconForge green minus icon

What is Arthrosi Therapeutics's IPO price?

The IPO price for Arthrosi Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Arthrosi Therapeutics?

Arthrosi Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Arthrosi Therapeutics share pre-IPO?

If you own Arthrosi Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Arthrosi Therapeutics a publicly traded company?

Arthrosi Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Arthrosi Therapeutics founded?

Arthrosi Therapeutics was founded in 2018.

Who are Arthrosi Therapeutics's major investors?

Reichstein Biotech
Guangrun Health Industry
Heda Ventures
Linghang Ventures
Changrong Capital
FengHe Fund Management
LTS Capital Advisors
Viva Biotech
JMCR Family Office
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.